CLVR - Clever Leaves expands presence in Brazil with partnership with Hypera Pharma
2023-04-18 08:55:11 ET
- Clever Leaves Holdings ( NASDAQ: CLVR ) has entered into a five-year agreement with Hypera Pharma in Brazil, to supply Clever Leaves’ CBD-dominant oral solutions with the aim of treating various medical conditions and prescribing to Brazilian patients.
- Clever Leaves’ leadership position in the region makes it uniquely equipped to enter and thrive in the Brazilian market, meeting all the regulatory and product quality requirements.
- The CBD products manufactured under this partnership have been registered under RDC 327 framework and are already being sold into distribution channels such as pharmacies and drugstores.
- "Expanding our presence in Brazil, a market that prioritizes patient treatment by enabling research and development to ensure technical and quality standards, will open doors for potential new developments and is further evidence of how our platform can support the global pharmaceutical industry by allowing it to engage in the world of cannabis-based therapies with patient safety and product quality at the forefront,” said Andres Fajardo, CEO of Clever Leaves.
For further details see:
Clever Leaves expands presence in Brazil with partnership with Hypera Pharma